PharmaCorp Rx (PCRX) 2026 Bloom Burton & Co. Healthcare Investor Conference summary

Conference highlights

• Presented at the 2026 Bloom Burton Healthcare Investor Conference, focusing on pharmacy roll-up strategies in Canada.

• Outlined a strategic alliance with PharmaChoice Canada, granting exclusive ROFR on 1,100–1,200 pharmacy locations.

• Announced a retail collaboration agreement with McKesson Canada, expanding acquisition opportunities beyond PharmaChoice stores.

• Shared recent capital raise at CAD 0.42 per share with warrants attached, and a CAD 100 million base shelf prospectus, with CAD 23 million available for deployment.

• Highlighted a growing acquisition pipeline and a staged, steady approach to expansion, with a focus on maintaining legacy and local ownership.

Business strategy and operations

• Targets pharmacies with at least CAD 2 million in revenue, CAD 350,000 EBITDA, and 35,000 prescriptions annually.

• Offers flexible exit options for owners, including partial buyouts, co-ownership, and equity participation.

• Emphasizes talent retention and co-ownership loans to junior pharmacists to ensure operational continuity.

• Focuses on stabilizing new acquisitions before implementing operational improvements, such as automation and front shop optimization.

• Prioritizes top-line growth in the first year post-acquisition, aiming for steady EBITDA increases rather than aggressive cost-cutting.

Industry trends and outlook

• Canadian pharmacy sector is recession resilient, with 85–90% of prescriptions funded by government or private plans.

• Aging population and expanded pharmacist scope of practice drive long-term demand for pharmacy services.

• Patient loyalty and continuity of care are key differentiators, with a focus on maintaining relationships post-acquisition.

• Pipeline includes both banner and independent pharmacies, with opportunities for consolidation and operational synergies.

• Anticipates significant growth in 2026, with new team hires and active deployment of capital for acquisitions.